We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
CVS Group Plc | AQSE:CVSG.GB | Aquis Stock Exchange | Ordinary Share | GB00B2863827 | Ordinary Shares 20p |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
20.00 | 2.34% | 875.00 | 740.00 | 1,170.00 | 955.00 | 867.62 | 885.00 | 539 | 16:29:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCVSG
RNS Number : 4644Z
CVS Group plc
12 January 2024
12 January 2024
CVS Group plc
("CVS" or the "Company")
Block Listing Interim Review
CVS, one of the UK's leading providers of integrated veterinary services, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements. References to securities are to the Company's ordinary shares of 0.2 pence each ("Ordinary Shares").
Name of the company: CVS Group plc Name of relevant scheme: 1. CVS Group plc 2017-2020 Sharesave Scheme; 2. CVS Group plc 2018-2021 SAYE Sharesave Scheme; and 3. CVS Group SAYE Plan 4. CVS Long Term Incentive Plan 2017 ------------------------------------------------------ Period From: 1 2 July 2023 To: 12 January 2024 of return: ------------- ----------------------- ----- ---------------------- Balance of unallotted 1. 230 securities under scheme(s) from previous return: 2. 12,864 3. 193,055* 4. 116,296 ------------------------------------------------------ Plus: The amount by 1. Nil which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 2. Nil 3. 350,000 4. 60,000 ------------------------------------------------------ Less: Number of securities 1. Nil issued / allotted under scheme(s) during period: 2. Nil 3. 150,600 4. 107,903 ------------------------------------------------------ Equals: Balance under 1. 230 scheme(s) not yet issued / allotted at end of period: 2. 12,864 3. 392,455 4. 68,393 ------------------------------------------------------ Number and class of 1. 114,302 Ordinary Shares admitted on securities originally 11 January 2021 and 1,535 Ordinary Shares listed and the date admitted on 1 September 2021 of admission: 2. 296,069 Ordinary Shares admitted on 1 September 2021 3. 350,000 Ordinary Shares admitted on 30 December 2021 4. 120,000 Ordinary Shares admitted on 15 May 2023 ------------------------------------------------------
*Incorrectly stated as 199,633 in the previous Block Listing Interim Review announcement on 12 July 2023.
The Company currently has ordinary shares of 0.2 pence each block listed under the following share plans:
1. CVS Group plc 2017-2020 Sharesave Scheme; and 2. CVS Group plc 2018-2021 SAYE Sharesave Scheme;
All outstanding share awards under the 2017 Sharesave Scheme have now vested or have lapsed and all outstanding options under the 2018 SAYE Sharesave Scheme have now been exercised or have lapsed. As a result, the block listings associated with these share plans have been cancelled and the above consists of their final block listing return.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRUASARSRUAAUR
(END) Dow Jones Newswires
January 12, 2024 02:00 ET (07:00 GMT)
1 Year CVS Chart |
1 Month CVS Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions